Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Kagoshima, Satsumasendai, Japan Clinical Trials

A listing of Kagoshima, Satsumasendai, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (1) clinical trials

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

Approximately 55 weeks: an up-to 2-week screening period, a 26-week randomized open-label treatment period, a 26-week safety extension treatment period and a 3-day post-treatment safety follow up period.

Phase

0.0 miles

Learn More »